ArticleCell death & disease2020

The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer.

Bianjiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.